Skip to main content

Objectives and achievements of regulations in developing countries

  • Chapter
International Medicines Regulations

Part of the book series: CMR Workshop Series ((CMRWS))

  • 40 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chiodomere E C (1984). Drug regulation in African countries: needs and expectations. Pharmacy International, 5(2), 37

    Google Scholar 

  2. Expert Committee of the Government of Bangladesh (1982). Report on Evaluation of Registered/Licensed Products and Draft National Drug Policy, Dacca p92

    Google Scholar 

  3. Jayasuriya D C (1985). Regulation of Pharmaceuticals in Developing Countries: Legal Issues and Approaches. (Geneva: World Health Organization)

    Google Scholar 

  4. Jayasuriya D C and Yeap Boon Chye (1987). Malaysia’s New Drug Regulations: Progress Through Co-operation. (Washington, Pharmaceutical Manufacturers Association) pp. 14–6

    Google Scholar 

  5. Jayasuriya D C (1985). The Public Health and Economic Dimensions of the New Drug Policy of Bangladesh. (Washington, Pharmaceutical Manufacturers Association)

    Google Scholar 

  6. Drugs (Control) Ordinance No VIII (1982). Ministry of Health and Population Control, Bangladesh

    Google Scholar 

  7. Chetley A (1985). Drug production with a social conscience: the experience of Gonoshasthaya Pharmaceuticals. Development Dialogue, 2, 100

    Google Scholar 

  8. World Health Organization (1987). Sources, Types and Availability of Information Concerning the Use of Drugs. In: The Rational Use of Drugs, pp. 96–108. (Geneva: WHO)

    Google Scholar 

  9. Patel M (1983). Drug costs in developing countries and policies to reduce them. World Development, 11 (3), 195–204

    Article  Google Scholar 

  10. Dukes M N G (1985). The Effects of Drug Regulations, pp. 45–6. (Lancaster: MTP Press)

    Google Scholar 

  11. UNIDO (1978). Growth of the Pharmaceutical Industry in Developing Countries: Problems and Prospects. (Vienna, United Nations Industrial Development Organization)

    Google Scholar 

  12. WHO, DANIDA and SIDA (1984). Report of a Project Preparation Mission on Essential Drugs for Primary Health Care in Bangladesh p. 12

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Jayasuriya, D.C. (1989). Objectives and achievements of regulations in developing countries. In: Walker, S.R., Griffin, J.P. (eds) International Medicines Regulations. CMR Workshop Series. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0857-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0857-4_15

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6873-4

  • Online ISBN: 978-94-009-0857-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics